Relationship between background cancer pain, breakthrough pain, and analgesic treatment: a preliminary study for a better interpretation of epidemiological and clinical studies

References

• Haugen D, Hjermstad M, Hagen N, et al. Assessment and classification of cancer breakthrough pain: a systematic literature review. Pain 2010;149:476-82
   PubMed Web of Science ®Google Scholar
• Mercadante S, Costanzo BV, Fusco F, et al. Breakthrough pain advanced cancer patients: a longitudinal study. Support Care Cancer 2009;38:554-60
   Google Scholar
• Mercadante S, Zagonel V, Breda E, et al. Breakthrough pain in oncology: a longitudinal study. J Pain Symptom Manage 2010;40:183-90
   PubMed Web of Science ®Google Scholar
• Davies A, Zeppetella G, Andersen S, et al. Multi-centre European study of breakthrough cancer pain: pain characteristics and patient perceptions of current and potential management strategies. Eur J Pain 2011;15:756-63
   PubMed Web of Science ®Google Scholar
• Portenoy RK, Hagen NA. Breakthrough pain: definition, prevalence and characteristics. Pain 1990;41:273-81
   PubMed Web of Science ®Google Scholar
• Serlin RC, Mendoza TR, Nakamura Y, et al. When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function. Pain 1995;61:277-84
   PubMed Web of Science ®Google Scholar
• Bennett D, Burton AW, Fishman S, et al. Consensus panel recommendations for the assessment and management of breakthrough pain. Part 2 – management. Pharm Ther 2005;30:354-61
   Google Scholar
• Hagen NA, Stiles C, Nekolaichuk C, et al. The Alberta breakthrough pain assessment tool for cancer patients. A validation study using a Delphi process and patient think-aloud interview. J Pain Symptom Manage 2008;35:136-52
   PubMed Web of Science ®Google Scholar
• Svendsen KB, Andersen S, Arnason S, et al. Breakthrough pain in malignant and non-malignant diseases: a review of prevalence, characteristics and mechanisms. Eur J Pain 2005;9:195-206
   PubMed Web of Science ®Google Scholar
• Swanwick M, Haworth M, Lennard RF. The prevalence of episodic pain in cancer: a survey of hospice patients on admission. Palliat Med 2001;15:9-18
   PubMed Web of Science ®Google Scholar
• Petzke F, Radbruch L, Zech D, et al. Temporal presentation of chronic cancer pain: transitory pains on admission to a multidisciplinary pain clinic. J Pain Symptom Manage 1999;17:391-401
   PubMed Web of Science ®Google Scholar
• Caraceni A, Martini C, Zecca E, et al. Working group of an IASP task force on cancer pain. Breakthrough pain characteristics and syndromes in patients with cancer pain. An international survey. Palliat Med 2004;18:177-83
   PubMed Web of Science ®Google Scholar
• Gómez-Batiste X, Madrid F, Moreno F, et al. Breakthrough cancer pain: prevalence and characteristics in patients in Catalonia, Spain. J Pain Symptom Manage 2002; 24:45-52
   PubMed Web of Science ®Google Scholar
• Zeppetella G, O’Doherty CA, Collins S. Prevalence and characteristics of breakthrough pain in cancer patients admitted to a hospice. J Pain Symptom Manage 2000;20:87-92
   PubMed Web of Science ®Google Scholar
• Mercadante S. Pharmacotherapy for breakthrough cancer pain. Drugs 2012;72:181-90
   PubMed Web of Science ®Google Scholar
• Greco MT, Corli O, Montanari M, et al. Epidemiology and pattern of care of breakthrough cancer pain in a longitudinal sample of cancer patients. Results from the Cancer Pain Outcome Research Study Group. Clin J Pain 2011;27:9-18
   PubMed Web of Science ®Google Scholar
• Caraceni A, Bertetto O, Labianca R, et al. Episodic (breakthrough) pain prevalence in a population of cancer pain patients. Comparison of clinical diagnoses with the QUDEI – Italian questionnaire for intense episodic pain. J Pain Symptom Manage 2012;43:833-41
   PubMed Web of Science ®Google Scholar
• Mercadante S. Breakthrough pain: on the road again. Eur J Pain 2009;13:329-30
   PubMed Web of Science ®Google Scholar
• Mercadante S. The use of rapid onset opioids for breakthrough cancer pain: the challenge of its dosing. Crit Rev Oncol Hematol 2011;80:460-5
   PubMed Web of Science ®Google Scholar
• Corli O, Montanari M, Greco MT, et al. How to evaluate the effect of pain treatments in cancer patients: results from a longitudinal outcomes and endpoint Italian cohort study. Eur J Pain 2012: published online 5 December 2012, doi: 10.1002/j.1532-2149.2012.00257.x
   Google Scholar
• Hwang SS, Chang VT, Kasimis B. Cancer breakthrough pain characteristics and responses to treatment at a VA medical center. Pain 2003;101:55-64
   PubMed Web of Science ®Google Scholar
• Mercadante S, Villari P, Ferrera P, Casuccio A. Optimization of opioid therapy for preventing incident pain associated with bone metastases. J Pain Symptom Manage 2004;28:505-10
   PubMed Web of Science ®Google Scholar
• Davies A, Dickman A, Reid C, et al. The management of cancer-related breakthrough pain: recommendations of a task group of the Association of Palliative Medicine of Great Britain and Ireland. Eur J Pain 2009;13:331-8
   PubMed Web of Science ®Google Scholar
• Mercadante S, Adile C, Torta R, et al. Meaningful cut-off pain intensity for breakthrough pain changes in advanced cancer patients. Curr Med Res Opin 2013;29:93-7
   PubMed Web of Science ®Google Scholar